![Johnson + Johnson](https://www.seeher.com/wp-content/uploads/2020/12/Screen-Shot-2020-03-27-at-10.41.20-AM-1.png)
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19. The parties have commenced preclinical testing of multiple vaccine prospects, with the aim to identify by the end of the month a COVID-19 vaccine candidate for clinical trials.